Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 4 | 2022 | 284 | 1.270 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2022 | 46 | 0.910 |
Why?
|
| Body Composition | 4 | 2022 | 119 | 0.910 |
Why?
|
| Chorioamnionitis | 3 | 2019 | 40 | 0.790 |
Why?
|
| Infant, Newborn | 16 | 2022 | 2455 | 0.600 |
Why?
|
| Body Size | 1 | 2016 | 39 | 0.550 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2016 | 72 | 0.540 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2015 | 27 | 0.520 |
Why?
|
| Gestational Age | 7 | 2022 | 389 | 0.480 |
Why?
|
| Body Weight | 1 | 2016 | 554 | 0.470 |
Why?
|
| Neuroimaging | 1 | 2015 | 122 | 0.470 |
Why?
|
| Child Development | 3 | 2014 | 102 | 0.420 |
Why?
|
| Adipose Tissue | 3 | 2022 | 221 | 0.400 |
Why?
|
| Developmental Disabilities | 3 | 2002 | 119 | 0.350 |
Why?
|
| Immunization | 2 | 2019 | 86 | 0.340 |
Why?
|
| Data Collection | 3 | 2019 | 420 | 0.320 |
Why?
|
| Fetal Growth Retardation | 2 | 2022 | 56 | 0.300 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2019 | 50 | 0.290 |
Why?
|
| Brain | 2 | 2015 | 2176 | 0.270 |
Why?
|
| Pregnancy | 9 | 2019 | 2334 | 0.240 |
Why?
|
| Psychology, Child | 1 | 2003 | 28 | 0.210 |
Why?
|
| Social Perception | 1 | 2003 | 44 | 0.210 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2002 | 57 | 0.210 |
Why?
|
| Adenosine Diphosphate | 1 | 2022 | 66 | 0.210 |
Why?
|
| Intensive Care, Neonatal | 1 | 2002 | 38 | 0.200 |
Why?
|
| Physicians, Family | 1 | 2002 | 83 | 0.200 |
Why?
|
| Hair | 1 | 2002 | 46 | 0.200 |
Why?
|
| Female | 17 | 2022 | 38074 | 0.200 |
Why?
|
| Weight Gain | 1 | 2022 | 135 | 0.190 |
Why?
|
| Infant | 5 | 2015 | 2891 | 0.170 |
Why?
|
| Caregivers | 1 | 2003 | 365 | 0.170 |
Why?
|
| Term Birth | 2 | 2015 | 12 | 0.160 |
Why?
|
| Humans | 23 | 2022 | 68618 | 0.160 |
Why?
|
| Language Disorders | 1 | 1998 | 22 | 0.160 |
Why?
|
| Bacterial Infections | 1 | 2019 | 163 | 0.150 |
Why?
|
| Mental Disorders | 1 | 2003 | 659 | 0.140 |
Why?
|
| Cocaine | 1 | 2002 | 555 | 0.140 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2017 | 56 | 0.140 |
Why?
|
| Biomarkers | 1 | 2002 | 1593 | 0.130 |
Why?
|
| Neuropsychological Tests | 1 | 1998 | 517 | 0.130 |
Why?
|
| Choline | 1 | 2015 | 14 | 0.130 |
Why?
|
| Creatine | 1 | 2015 | 30 | 0.130 |
Why?
|
| Basal Ganglia | 1 | 2015 | 45 | 0.130 |
Why?
|
| Psychometrics | 1 | 1998 | 514 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 78 | 0.130 |
Why?
|
| Dipeptides | 1 | 2015 | 89 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2015 | 86 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 1465 | 0.120 |
Why?
|
| Male | 12 | 2017 | 37321 | 0.120 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 292 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2015 | 737 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2016 | 867 | 0.110 |
Why?
|
| Inflammation | 2 | 2017 | 1030 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1046 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 296 | 0.100 |
Why?
|
| Growth Charts | 1 | 2012 | 16 | 0.100 |
Why?
|
| Sensitivity and Specificity | 3 | 2002 | 1753 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 772 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2077 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 1990 | 9 | 0.090 |
Why?
|
| Candida albicans | 1 | 1990 | 39 | 0.090 |
Why?
|
| Risk Factors | 4 | 2019 | 5731 | 0.090 |
Why?
|
| Thrombocytopenia | 1 | 1989 | 122 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2014 | 3705 | 0.080 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2007 | 4 | 0.070 |
Why?
|
| Myelitis | 1 | 2007 | 9 | 0.070 |
Why?
|
| Encephalitis | 1 | 2007 | 43 | 0.070 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2007 | 42 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 1989 | 481 | 0.070 |
Why?
|
| Birth Weight | 2 | 2011 | 186 | 0.070 |
Why?
|
| Vaccination | 1 | 2007 | 189 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 1985 | 69 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2016 | 7277 | 0.060 |
Why?
|
| Transportation of Patients | 1 | 2002 | 46 | 0.050 |
Why?
|
| Neurology | 1 | 2002 | 43 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2002 | 91 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 1985 | 597 | 0.050 |
Why?
|
| Child | 2 | 2003 | 6405 | 0.040 |
Why?
|
| Maternal Health | 1 | 2019 | 8 | 0.040 |
Why?
|
| Parents | 1 | 2003 | 312 | 0.040 |
Why?
|
| Vision Tests | 1 | 1999 | 18 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 1999 | 32 | 0.040 |
Why?
|
| Language Tests | 1 | 1999 | 36 | 0.040 |
Why?
|
| Asphyxia Neonatorum | 1 | 1999 | 14 | 0.040 |
Why?
|
| Hearing Tests | 1 | 1999 | 70 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 1999 | 93 | 0.040 |
Why?
|
| Sampling Studies | 1 | 1998 | 80 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 1999 | 114 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 7029 | 0.040 |
Why?
|
| Phosphorus | 1 | 2017 | 64 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 546 | 0.040 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2017 | 58 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1998 | 154 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2017 | 116 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 3259 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2003 | 2800 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2014 | 57 | 0.030 |
Why?
|
| Time Factors | 2 | 2017 | 4655 | 0.030 |
Why?
|
| Mass Screening | 1 | 1999 | 843 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1553 | 0.030 |
Why?
|
| Androstane-3,17-diol | 1 | 1992 | 3 | 0.030 |
Why?
|
| Child, Preschool | 1 | 1999 | 3187 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 866 | 0.030 |
Why?
|
| Vitamin D | 1 | 2017 | 516 | 0.030 |
Why?
|
| Plethysmography | 1 | 2012 | 17 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1992 | 131 | 0.030 |
Why?
|
| Adult | 3 | 2012 | 21403 | 0.020 |
Why?
|
| Fetal Weight | 1 | 2011 | 33 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2011 | 79 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 705 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2358 | 0.020 |
Why?
|
| Hemagglutination Tests | 1 | 1990 | 16 | 0.020 |
Why?
|
| Premature Birth | 1 | 2012 | 150 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1266 | 0.020 |
Why?
|
| Immunity | 1 | 1990 | 67 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1342 | 0.020 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1989 | 4 | 0.020 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1989 | 13 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 1989 | 21 | 0.020 |
Why?
|
| Platelet Count | 1 | 1989 | 100 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1989 | 215 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1998 | 1242 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1989 | 284 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1989 | 205 | 0.020 |
Why?
|
| Colostrum | 1 | 1987 | 6 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1987 | 32 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1989 | 951 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 145 | 0.020 |
Why?
|
| Adolescent | 1 | 1999 | 8912 | 0.020 |
Why?
|
| Autoantibodies | 1 | 1989 | 434 | 0.020 |
Why?
|
| Amino Acids | 1 | 1987 | 131 | 0.020 |
Why?
|
| Milk, Human | 1 | 1987 | 147 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1985 | 41 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1985 | 199 | 0.010 |
Why?
|
| Anemia, Neonatal | 1 | 2002 | 6 | 0.010 |
Why?
|
| Convalescence | 1 | 2002 | 11 | 0.010 |
Why?
|
| Apnea | 1 | 2002 | 16 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2002 | 29 | 0.010 |
Why?
|
| Neonatology | 1 | 2002 | 29 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1985 | 511 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5717 | 0.010 |
Why?
|
| Hypoxia, Brain | 1 | 1999 | 16 | 0.010 |
Why?
|
| Neonatal Screening | 1 | 1998 | 43 | 0.010 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1998 | 27 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 1999 | 665 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1992 | 58 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 1992 | 23 | 0.010 |
Why?
|
| Pregnancy Trimester, First | 1 | 1992 | 43 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 2550 | 0.010 |
Why?
|
| Infant Food | 1 | 1987 | 16 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1987 | 164 | 0.000 |
Why?
|
| Ammonia | 1 | 1987 | 28 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 381 | 0.000 |
Why?
|
| Animals | 1 | 1999 | 20881 | 0.000 |
Why?
|